Heat shock protein 60 activates cytokine-associated negative regulator suppressor of cytokine signaling 3 in T cells: Effects on signaling, chemotaxis, and inflammation

Journal of Immunology

Volumn 175, Issue 1, 2005, Pages 276-285

  Zanin Zhorov, Alexandra ^a   Tal, Guy ^a   Shivtiel, Shoham ^a   Cohen, Michal ^a   Lapidot, Tsvee ^a   Nussbaum, Gabriel ^a   Margalit, Raanan ^a   Cohen, Irun R ^a   Lider, Ofer ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; FOCAL ADHESION KINASE 2; HEAT SHOCK PROTEIN 60; LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN LIGHT CHAIN; PROTEIN KINASE B; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW; CELL ADHESION; CELL COMMUNICATION; CELL MIGRATION; CELL POLARITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION;

EID: 21244489948     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.1.276     Document Type: Article

References (50)

1. Foxman, E. F., J. J. Campbell, and E. C. Butcher. 1997. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 139: 1349-1360.
2. Zanin-Zhorov, A., R. Hershkoviz, I. Hecht, L. Cahalon, and O. Lider. 2003. Fibronectin-associated Fas ligand rapidly induces opposing and time-dependent effects on the activation and apoptosis of T cells. J. Immunol. 171: 5882-5889.
3. Wallin, R. P., A. Lundqvist, S. H. More, A. von Bonin, R. Kiessling, and H. G. Ljunggren. 2002. Heat-shock proteins as activators of the innate immune system. Trends Immunol. 23: 130-135.
4. Kol, A., T. Bourcier, A. H. Lichtman, and P. Libby. 1999. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J. Clin. Invest. 103: 571-577.
5. van Eden, W., J. E. Thole, R. van der Zee, A. Noordzij, J. D. van Embden, E. J. Hensen, and I. R. Cohen. 1988. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331: 171-173.
6. Yokota, S. I., D. Hirata, S. Minota, T. Higashiyama, M. Kurimoto, H. Yanagi, T. Yura, and H. Kubota. 2000. Autoantibodies against chaperonin CCT in human sera with rheumatic autoimmune diseases: comparison with antibodies against other HSP60 family proteins. Cell Stress Chaperones 5: 337-346.
7. Xu, Q., G. Schett, H. Perschinka, M. Mayr, G. Egger, F. Oberhollenzer, J. Willeit, S. Kiechl, and G. Wick. 2000. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102: 14-20.
8. Laplante, A. F., V. Moulin, F. A. Auger, J. Landry, H. Li, G. Morrow, R. M. Tanguay, and L. Germain. 1998. Expression of heat shock proteins in mouse skin during wound healing. J. Histochem. Cytochem. 46: 1291-1301.
9. Ohashi, K., V. Burkart, S. Flohé, and H. Kolb. 2000. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164: 558-561.
10. Elias, D., A. Meilin, V. Ablamunits, O. S. Birk, P. Carmi, S. Konen-Waisman, and I. R. Cohen. 1997. HSP60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various β-cell antigens. Diabetes 46: 758-764.
11. Quintana, F. J., P. Carmi, and I. R. Cohen. 2002. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J. Immunol. 169: 6030-6035.
12. Zanin-Zhorov, A., G. Nussbaum, S. Franitza, I. R. Cohen, and O. Lider. 2003. T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J. 17: 1567-1569.
13. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272: 60-66.
14. Sallusto, F., A. Lanzavecchia, and C. R. Mackay. 1998. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 19: 568-574.
15. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242.
16. + progenitors to peripheral blood. J. Exp. Med. 185: 111-120.
17. Bleul, C. C., R, C. Fuhlbrigge, J. M. Casasnovas, A. Aiuti, and T. A. Springer. 1996. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184: 1101-1109.
18. i-coupled phosphoinositide 3-kinase in T lymphocytes. J. Immunol. 163: 5954-5963.
19. Ganju, R. K., S. A. Brubaker, J. Meyer, P. Dutt, Y. Yang, S. Qin, W. Newman, and J. E. Groopman. 1998. The α-chemokine, stromal cell-derived factor-1α, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J. Biol. Chem. 273: 23169-23175.
20. Vicente-Manzanares, M., J. R. Cabrero, M. Rev, M. Pérez- Martínez, A. Ursa, K. Itoh, and F. Sánchez-Madrid. 2002. A role for the Rho-p160 Rho coiled-coil kinase axis in the chemokine stromal cell-derived factor-1α-induced lymphocyte actomyosin and microtubular organization and chemotaxis. J. Immunol. 168: 400-410.
21. Vila-Coro, A. J., J. M. Rodríguez-Frade, A. Martín De Ana, M. C. Moreno-Ortíz, C. Martínez-A, and M. Mellado. 1999. The chemokine SDF-1α triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13: 1699-1710.
22. Soriano, S. F., P. Hernanz-Falcón, J. M. Rodríguez-Frade, A. Martín De Ana, R. Garzón, C. Carvalho-Pinto, A. J. Vila-Coro, A. Zaballos, D. Balomenos, C. Martínez-A, and M. Mellado. 2002. Functional inactivation of CXC chemokine receptor 4-mediated responses through SOCS3 up-regulation. J. Exp. Med. 196: 311-321.
23. Raz, I., D. Elias, A. Avron, M. Tamir, M. Melzger, and I. R. Cohen. 2001. β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 358: 1749-1753.
24. Ponomaryov, T., A. Peled, I. Petit, R. S. Taichman, L. Habler, J. Sandbank, F. Arenzana-Seisdedos, A. Magerus, A. Caruz, N. Fujii, et al. 2000. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J. Clin. Invest. 106: 1331-1339.
25. null mice. Blood 97: 3283-3291.
26. Grimm, M. C., R. Newman, Z. Hassim, N. Cuan, S. J. Connor, Y. Le, J. M. Wang, J. J. Oppenheim, and A. R. Lloyd. 2003. Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by transdeactivating chemokine receptors. J. Immunol. 171: 4990-4994.
27. English, J., G. Pearson, J. Wilsbacher, J. Swantek, M. Karandikar, S. Xu, and M. H. Cobb. 1999. New insights into the control of MAP kinase pathways. Exp. Cell Res. 253: 255-270.
28. + T lymphocytes. Eur. J. Immunol. 28: 3867-3877.
29. Sieg, D. J., C. R. Hauck, D. Ilic, C. K. Klingbeil, E. Schaefer, C. H. Damsky, and D. D. Schlaepfer. 2000. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2: 249-256.
30. Zrihan-Licht, S., Y. Fu, J. Settleman, K. Schinkmann, L. Shaw, I. Keydar, S. Avraham, and H. Avraham. 2000. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Oncogene 19: 1318-1328.
31. Vicente-Manzanares, M., M. Rey, D. R. Jones, D. Sancho, M. Mellado, J. M. Rodriguez-Frade, M. A. del Pozo, M. Yáñez-Mó, A. M. de Ana, C. Martínez-A, et al. 1999. Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1α-induced lymphocyte polarization and chemotaxis. J. Immunol. 163: 4001-4012.
32. Thelen, M., M. Uguccioni, and J. Bosiger. 1995. PI 3-kinase-dependent and independent chemotaxis of human neutrophil leukocytes. Biochem. Biophys. Res. Commun. 217: 1255-1262.
33. Yoshioka, K., F. Matsumura, H. Akedo, and K. Itoh. 1998. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J. Biol. Chem. 273: 5146-5154.
34. Sancho, D., M. Vicente-Manzanares, M. Mittelbrunn, M. C. Montoya, M. Gordon-Alonso, J. M. Serrador, and F. Sánchez-Madrid. 2002. Regulation of microtubuie-organizing center orientation and actomyosin cytoskeleton rearrangement during immune interactions. Immunol. Rev. 189: 84-97.
35. Alexander, W. S., R. Starr, D. Metcalf, S. E. Nicholson, A. Farley, A. G. Elefanty, M. Brysha, B. T. Kile, R. Richardson, M. Baca, et al. 1999. Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction. J. Leukocyte Biol. 66: 588-592.
36. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921.
37. Kubo, M., T. Hanada, and A. Yoshimura. 2003. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4: 1169-1176.
38. Dalpke, A. H., S. Eckerle, M. Frey, and K. Heeg. 2003. Triggering of Toll-like receptors modulates IFN-γ signaling: involvement of serine 727 STAT1 phosphorylation and suppressors of cytokine signaling. Eur. J. Immunol. 33: 1776-1787.
39. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284-288.
40. Tsan, M. F., and B. Gao. 2004. Cytokine function of heat shock proteins. Am. J. Physiol. 286: C739-C744.
41. Lee, H. K., J. Lee, and P. S. Tobias. 2002. Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J. Immunol. 168: 4012-4017.
42. Gao, B., and M. F. Tsan. 2003. Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor α from murine macrophages. J. Biol. Chem. 278: 22523-22529.
43. Zanin-Zhorov, A., R. Bruck, G. Tal, S. Oren, H. Aeed, R. Hershkoviz, I. R. Cohen, and O. Lider. 2005. Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines. J. Immunol. 174: 3227-3236.
44. Fan, J., and A. B. Malik. 2003. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat. Med. 9: 315-321.
45. Komai-Koma, M., L. Jones, G. S. Ogg, D. Xu, and F. Y. Liew. 2004. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. USA 101: 3029-3034.
46. Muzio, M., N. Polentarutti, D. Bosisio, P. P. Manoj Kumar, and A. Mantovani. 2000. Toll-like receptor family and signalling pathway. Biochem. Soc. Trans. 28: 563-566.
47. Johnson, G. B., G. J. Brunn, A. H. Tang, and J. L. Platt. 2003. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol. 24: 19-24.
48. Feuerer, M., P. Beckhove, N. Garbi, Y. Mahnke, A. Limmer, M. Hommel, G.J., Hämmerling, B. Kyewski, A. Hamann, V. Umansky, and V. Schirrmacher. 2003. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat. Med. 9: 1151-1157.
49. Pockley, A. G. 2002. Heat shock proteins, inflammation, and cardiovascular disease. Circulation 105: 1012-1017.
50. H2-mediated allergic responses. Nat. Med. 9: 1047-1054.